Dr. Paul M. Hassoun, MD

Dr. Hassoun practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. Hassoun's NPI, 1083664387, was assigned on May 10, 2006. Dr. Hassoun holds Maryland license D59427.

Dr. Hassoun's primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. Hassoun's primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. Hassoun is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Hassoun to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hassoun practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Hassoun's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Hassoun is licensed in Maryland.

CMS data shows 412 Medicare services from Dr. Hassoun across 6 procedure codes in 2024, for 132 Medicare patients. Medicare paid $28,785 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 132 Medicare patients who saw Dr. Hassoun in 2024. The largest group is 65 to 74, with 46 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hassoun's median patient age at 73, with 75% women.

In 2024, Dr. Hassoun wrote 499 Medicare Part D claims for 59 patients. 75% of them were for generic drugs. CMS names the drug for 402 of them, across 12 drugs with 11 or more claims each, at $1,616,287 in total drug cost. In 2023, CMS named 282 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Hassoun for performance year 2024, reported as part of a group.

Dmand AI links 149 papers to Dr. Hassoun, published from 2014 to 2025. 2024 was the busiest year, with 22. The most frequent topics are Hypertension, Pulmonary, Pulmonary Arterial Hypertension and Ventricular Dysfunction, Right. Dr. Hassoun has published most often in Pulm Circ. Dr. Hassoun's most frequent co-authors are Rachel Lynn Damico, MD, PhD, Stephen Carl Mathai, MD, MHS and Todd Matthew Kolb, MD, PhD.

CMS Open Payments shows 100 general payments to Dr. Hassoun from 6 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. Merck Sharp & Dohme Corporation paid the most, $65,572.